Exosome Clinical Trials

8 recruitingLast updated: May 29, 2026

There are 8 actively recruiting exosome clinical trials across 5 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Baltimore, Maryland, United States, Bandung, West Java, Indonesia, Changsha, Hunan, China. Updated daily from ClinicalTrials.gov.


Exosome Trials at a Glance

8 actively recruiting trials for exosome are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Baltimore, Bandung, and Changsha. Lead sponsors running exosome studies include Hunan Children's Hospital, Kafrelsheikh University, and Biological Dynamics.

Browse exosome trials by phase

Treatments under study

About Exosome Clinical Trials

Looking for clinical trials for Exosome? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Exosome trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Exosome clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

A Randomized Trial of Intratympanic Drug Delivery: Evaluating the Efficacy and Safety of Dexamethasone-Loaded Exosomes Versus Standard Therapy in Acute Sensorineural Hearing Loss.

ExosomesSensori-Neural Deafness
Kafrelsheikh University30 enrolled1 locationNCT07568184
Recruiting

Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death

Sudden Cardiac DeathExosome MultiomicsClinical Prognosis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School300 enrolled1 locationNCT06856993
Recruiting

Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis

Colorectal, CancerPathologyLiver Metastases From Colorectal Cancer+2 more
Mu-qing Yang260 enrolled1 locationNCT07177742
Recruiting
Phase 1

A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects

Targeted TherapyExosomeHealthy Subjects
Shine-On Biomedical Co., Ltd.15 enrolled1 locationNCT07219940
Recruiting
Not Applicable

Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer

Breast CancerGynecologic CancerCirculating Tumor DNA+2 more
Poitiers University Hospital1,000 enrolled1 locationNCT04530890
Recruiting
Phase 1Phase 2

MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction

PostpartumPreeclampsiaCell Therapy+2 more
Universitas Padjadjaran80 enrolled1 locationNCT07183384
Recruiting

ExoLuminate Study for Early Detection of Pancreatic Cancer

Pancreas CancerExosomesPancreatic Neoplasms+1 more
Biological Dynamics1,000 enrolled1 locationNCT05625529
Recruiting

Exosome microRNAs as Potential Biomarkers of Metabolic Bone Disease of Prematurity

ExosomesBone Diseases, MetabolicNewborn
Hunan Children's Hospital200 enrolled1 locationNCT06368154